Compounds > 5-(4-piperidyl)isoxazol-3-ol
Page last updated: 2024-09-03

5-(4-piperidyl)isoxazol-3-ol and Central Nervous System Disease

5-(4-piperidyl)isoxazol-3-ol has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebert, B; Frølund, B; Kristiansen, U; Krogsgaard-Larsen, P; Liljefors, T1

Reviews

1 review(s) available for 5-(4-piperidyl)isoxazol-3-ol and Central Nervous System Disease

ArticleYear
GABA(A) receptor ligands and their therapeutic potentials.
    Current topics in medicinal chemistry, 2002, Volume: 2, Issue:8

    Topics: Animals; Central Nervous System Diseases; GABA Agents; GABA Agonists; GABA Antagonists; Humans; Isonicotinic Acids; Isoxazoles; Ligands; Muscimol; Piperidines; Protein Subunits; Receptors, GABA-A

2002